Results 61 to 70 of about 2,217 (170)

NOOTROPICS AGENTS: PHARMACEUTICAL ASPECT, COMMON EXAMPLES AND THEIR APPLICATIONS

open access: yesJournal of Drug Delivery and Therapeutics, 2018
Nootropics compounds are one of the important categories of medicinal agents act as cognitive enhancers and neuroprotective. These agents mainly used to improve memory related functioning of brain. Nootropic compounds exhibited various neural activities and boost functioning of central nervous system including improvement of intellectual, memory and ...
openaire   +2 more sources

Behavioral and biomarker assessment of flavonols as multifunctional neuroprotective nootropic agents

open access: yesFuture Medicinal Chemistry
This study aimed to evaluate the behavioral and biochemical effects of synthesized flavonols (1-10) as potential nootropic, antidepressant, and antistress agents.Behavioral assessments were conducted using animal models to evaluate memory impairment, depression, and stress responses.
Ehsan Ullah Mughal   +9 more
openaire   +3 more sources

Subjective cognitive impairment as a manifestation of Alzheimer's disease or emotional disorders

open access: yesНеврология, нейропсихиатрия, психосоматика
Cognitive impairment (CI) is one of the most common types of neurological disorders and a frequent cause of disability. However, in 20–30% of patients who visit specialized centers (memory clinics) with cognitive complaints, no abnormalities are detected
D. A. Grishina   +2 more
doaj   +1 more source

A comparative chemoreactome analysis of choline alfoscerate and ethylmethylhydroxypyridine succinate molecules

open access: yesНеврология, нейропсихиатрия, психосоматика
The combined use of neuroprotective agents and nootropic drugs with different mechanisms of action represents a promising avenue in the pharmacotherapy of impaired attention and memory, chronic cerebral ischemia, ischemic stroke, senile dementia and ...
O. A. Gromova, I. Yu. Torshin
doaj   +1 more source

Neuroprotective effects of a new nootropic agent Mitochondrin-2 [PDF]

open access: yesFiziolohichnyĭ zhurnal, 2020
K.A. Dronska   +4 more
openaire   +1 more source

Effect of piracetam, a nootropic agent, on experimental gastric ulcers in rat.

open access: yesIndian journal of experimental biology, 1990
Piracetam, used clinically for cognitive disorders, was found to have significant anti-ulcerogenic activity against immobilization stress- and aspirin-induced gastric ulcers in rats. The anti-ulcer effect of piracetam was exerted by augmentation of mucosal resistance.
R K, Goel   +4 more
openaire   +1 more source

Latency of memory consolidation induced in mice by piracetam, a nootropic agent.

open access: yesIndian journal of experimental biology, 1994
Piracetam (PIR), a cyclic GABA derivative, is the prototype of a new class of psychoactive drugs, the nootropic agents, which improve learning acquisition and the retention of the learning as memory. It was proposed that nootropics act on processes essentially involved in information storage, thus facilitating memory.
S K, Bhattacharya   +3 more
openaire   +1 more source

Nootropic activity of methanolic extract from Evolvulus alsinoides Linn. in mice with scopolamine-induced amnesia. [PDF]

open access: yesBioinformation, 2023
Nithya K   +4 more
europepmc   +1 more source

Comparable improvements in selective, but not sustained, attention in response to a multi-ingredient nootropic formulation when compared with caffeine. [PDF]

open access: yesEur J Nutr
Hearris MA   +8 more
europepmc   +1 more source

Utilization of psychotropic drugs in Serbia from 2006 to 2021: Patterns before and during the COVID-19 pandemic. [PDF]

open access: yesPLoS One
Filimonovic J   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy